OWP
RYTM icon

ORG Wealth Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

ORG Wealth Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,206
Closed -$67.5K – 802
2024
Q4 		$67.5K Hold
1,206
– – 0.02% 232
2024
Q3 		$63.2K Buy
+1,206
New +$57.8K 0.02% 231

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORG Wealth Partners's RYTM Position: Q1 2025 in Review

ORG Wealth Partners sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2025, closing a stake of 1,206 shares — an estimated $67.5K sold.

ORG Wealth Partners first reported a position in RYTM in Q3 2024 and held it in 2 quarters. The position peaked at $67.5K in Q4 2024. 228 funds tracked by Wall St. Rank hold RYTM as of Q1 2025.

  • ORG Wealth Partners reported no remaining Rhythm Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • ORG Wealth Partners sold 1,206 Rhythm Pharmaceuticals shares in Q1 2025, an estimated $67.5K.
  • ORG Wealth Partners first reported a position in Rhythm Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • ORG Wealth Partners's Rhythm Pharmaceuticals position peaked at $67.5K in Q4 2024.
  • 228 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2025.

Based on ORG Wealth Partners's 13F filing for Q1 2025, filed 21 Apr 2025.